Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › multiple organ dysfunction

Multiple organ dysfunction

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for multiple organ dysfunction

2 trials tracked for multiple organ dysfunction.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 1 Other / NA 1
  1. Phase 2 Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients Completed
  2. N/A NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Hemodiafiltration in Neonates: Narrative Review Maps Applications but Reports No Clinical Outcomes
Pediatrics Sys. Review
Hemodiafiltration in Neonates: Narrative Review Maps Applications but Reports No Clinical Outcomes Hemodiafiltration in Babies: What We Still Do Not Know
This narrative review examines hemodiafiltration (HDF) in neonates and infants, focusing on clinical applications, potential benefits, safet…
A new review looks at hemodiafiltration for newborns and infants, but reports no actual results or safety data.
Frontiers Oct 10, 2026
Case report and literature review of severe adverse reactions following pucotenlimab treatment
Allergy & Immunology Sys. Review
Case report and literature review of severe adverse reactions following pucotenlimab treatment New drug treatment linked to severe neurological reactions
This case report and literature review describes severe adverse reactions following treatment with pucotenlimab in a patient with advanced b…
A single patient facing advanced breast cancer experienced life-threatening neurological symptoms after receiving the drug pucotenlimab.
Frontiers Apr 30, 2026
Narrative review of Dachengqi Decoction for sepsis-induced organ injury
Drug Pipeline Sys. Review
Narrative review of Dachengqi Decoction for sepsis-induced organ injury Dachengqi Decoction may protect organs during dangerous sepsis attacks
This narrative review summarizes evidence that Dachengqi Decoction (DCQD) and its bioactive metabolites may protect against sepsis-induced i…
A traditional Chinese medicine formula shows promise for stopping organ damage in sepsis patients by calming the body's extreme immune react…
Frontiers Apr 28, 2026